MPMichelle Paulsen

Michelle Paulsen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michelle Paulsen has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Transcriptional regulation of the thymus master regulatorFoxn1

    by Noam Kadouri, Tal Givony, Shir Nevo, Joschka Hey, Shifra Ben Dor, Golda Damari, Bareket Dassa, Jan Dobes, Dieter Weichenhan, Marion Bähr, et al.

    FOXN1 is a transcription factor critical for the development of both thymic epithelial cell (TEC) and hair follicle cell (HFC) compartments. However, mechanisms controlling its expression remain poorly understood. To address this question, we performed thorough analyses of the evolutionary conservation and chromatin status of theFoxn1locus in different tissues and states and identified several putative cis-regulatory regions unique to TECs versus HFCs. Furthermore, experiments using genetically modified mice with specific deletions in theFoxn1locus and additional bioinformatic analyses helped us identify key regions and transcription factors involved in either positive or negative regulation ofFoxn1in both TECs and HFCs. Specifically, we identified SIX1 and FOXN1 itself as key factors inducingFoxn1expression in embryonic and neonatal TECs. Together, our data provide important mechanistic insights into the transcriptional regulation of theFoxn1gene in TEC versus HFC and highlight the role of FOXN1 in its autoregulation.


  • Open Access

    Type I interferons and MAVS signaling are necessary for tissue resident memory CD8+ T cell responses to RSV infection

    by Augusto Varese, Joy Nakawesi, Ana Farias, Freja C. M. Kirsebom, Michelle Paulsen, Rinat Nuriev, Cecilia Johansson

    Respiratory syncytial virus (RSV) can cause bronchiolitis and viral pneumonia in young children and the elderly. Lack of vaccines and recurrence of RSV infection indicate the difficulty in eliciting protective memory immune responses. Tissue resident memory T cells (TRM) can confer protection from pathogen re-infection and, in human experimental RSV infection, the presence of lung CD8+ TRM cells correlates with a better outcome. However, the requirements for generating and maintaining lung TRM cells during RSV infection are not fully understood. Here, we use mouse models to assess the impact of innate immune response determinants in the generation and subsequent expansion of the TRM cell pool during RSV infection. We show that CD8+ TRM cells expand independently from systemic CD8+ T cells after RSV re-infection. Re-infected MAVS and MyD88/TRIF deficient mice, lacking key components involved in innate immune recognition of RSV and induction of type I interferons (IFN-α/β), display impaired expansion of CD8+ TRM cells and reduction in antigen specific production of granzyme B and IFN-γ. IFN-α treatment of MAVS deficient mice during primary RSV infection restored TRM cell expansion upon re-challenge but failed to recover TRM cell functionality. Our data reveal how innate immunity, including the axis controlling type I IFN induction, instructs and regulates CD8+ TRM cell responses to RSV infection, suggesting possible mechanisms for therapeutic intervention.


  • Open Access

    Epigenetic reprogramming of airway macrophages promotes polarization and inflammation in muco-obstructive lung disease

    by Joschka Hey, Michelle Paulsen, Reka Toth, Dieter Weichenhan, Simone Butz, Jolanthe Schatterny, Reinhard Liebers, Pavlo Lutsik, Christoph Plass, Marcus A. Mall

    Lung diseases, such as cystic fibrosis and COPD, are characterized by mucus obstruction and chronic airway inflammation, but their mechanistic link remains poorly understood. Here, we focus on the function of the mucostatic airway microenvironment on epigenetic reprogramming of airway macrophages (AM) and resulting transcriptomic and phenotypical changes. Using a mouse model of muco-obstructive lung disease (Scnn1b-transgenic), we identify epigenetically controlled, differentially regulated pathways and transcription factors involved in inflammatory responses and macrophage polarization. Functionally, AMs from Scnn1b-transgenic mice have reduced efferocytosis and phagocytosis, and excessive inflammatory responses upon lipopolysaccharide challenge, mediated through enhanced Irf1 function and expression. Ex vivo stimulation of wild-type AMs with native mucus impairs efferocytosis and phagocytosis capacities. In addition, mucus induces gene expression changes, comparable with those observed in AMs from Scnn1b-transgenic mice. Our data show that mucostasis induces epigenetic reprogramming of AMs, leading to changes favoring tissue damage and disease progression. Targeting these altered AMs may support therapeutic approaches in patients with muco-obstructive lung diseases.


  • Open Access

    Correction: Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin

    by Artur Veloso, Benjamin Biewen, Michelle T. Paulsen, Nathan Berg, Leonardo Carmo De Andrade Lima, Jayendra Prasad, Karan Bedi, Brian Magnuson, Thomas E. Wilson, Mats Ljungman